The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab

Published:2010-09-05 Issue:12 Volume:49 Page:2408-2412
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Shima Y.,Kuwahara Y.,Murota H.,Kitaba S.,Kawai M.,Hirano T.,Arimitsu J.,Narazaki M.,Hagihara K.,Ogata A.,Katayama I.,Kawase I.,Kishimoto T.,Tanaka T.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/49/12/2408/5065454/keq275.pdf

Reference14 articles.

1. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis

2. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

3. Preliminary criteria for the classification of systemic sclerosis (scleroderma)

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies in the Management of Inflammation in Wound Healing: An Updated Literature Review;Journal of Clinical Medicine;2024-07-12

2. Case report: Nodular scleroderma successfully treated with tocilizumab;International Journal of Rheumatic Diseases;2024-05

3. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH;Cytokine;2024-04

4. Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial;Modern Rheumatology;2023-07-04

5. When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis;Frontiers in Immunology;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3